Plus Therapeutics Reports Second Quarter 2020 Financial and Business Results
AUSTIN, Texas, Aug. 10, 2020 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), today announced financial and business results […]
CDW Corporation Announces Proposed Registered Offering of $630 Million of Senior Notes due 2029
LINCOLNSHIRE, Ill., Aug. 10, 2020 (GLOBE NEWSWIRE) — CDW Corporation (NASDAQ: CDW), a leading multi-brand technology solutions provider to business, […]
Aemetis to Review Second Quarter Financial Results on August 13, 2020
CUPERTINO, CA, Aug. 10, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE – Aemetis, Inc. (NASDAQ: AMTX) announced that the company will […]
Intra-Cellular Therapies Reports Second Quarter 2020 Financial Results and Provides Corporate Update
NEW YORK, Aug. 10, 2020 (GLOBE NEWSWIRE) — Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development […]
Revolution Medicines Reports Second Quarter 2020 Financial Results and Provides Update on Corporate Progress
Interim RMC-4630 Data Support Benefit of Intermittent Dosing and Corroborate Clinical Activity Against Genetically-Defined TumorsTargeted Combination Strategy Underpins Initiation of […]
Paratek Pharmaceuticals Announces Second Quarter 2020 Total Revenue of $9.3 Million including NUZYRA® (omadacycline) Net Revenue of $8.1 Million
— Paratek Raises Full Year 2020 Revenue Guidance; Total Revenue guidance expected to be Between $78 and $83 Million Driven by Strong NUZYRA Net Revenue— [...]
Aquestive Therapeutics Receives FDA Fast Track Designation for AQST-108 (Sublingual Film Formulation Delivering Systemic Epinephrine) for Treatment of Allergic Reactions Including Anaphylaxis
Finalizing preparations for pharmacokinetic (PK) clinical trials of AQST-108First planned PK clinical trial expected to begin during the third quarter […]
Ocugen Receives Fourth FDA Orphan Drug Designation for the Same Product, OCU400 (AAV-NR2E3) Gene Therapy, for the Treatment of Another Key Inherited Retinal Disease (IRD), PDE6B Gene Mutation-Associated Retinal Diseases
MALVERN, Pa., Aug. 10, 2020 (GLOBE NEWSWIRE) — Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and […]
Gilat Awarded Over $10 Million for a Five-Year Service Project for 4G Backhaul Services in Latin America
PETAH TIKVA, Israel, Aug. 10, 2020 (GLOBE NEWSWIRE) — Gilat Satellite Networks Ltd. (NASDAQ, TASE: GILT), a worldwide leader in […]
Helius Medical Technologies to Release Second Quarter of Fiscal Year 2020 Financial Results on August 12, 2020
NEWTOWN, Pa., Aug. 10, 2020 (GLOBE NEWSWIRE) — Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech […]
